Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating whether a prehospital triage strategy using the modified HEAR score and high-sensitivity point-of-care troponin testing can improve the diagnosis and management of patients aged 18 and older with intermediate to high risk of non-ST elevation acute coronary syndrome NSTE-ACS. This randomized clinical trial aims to assess if this approach is cost-effective and not worse in terms of major adverse cardiac events MACE compared to the usual care of transporting patients to the nearest hospital for assessment. The study seeks to provide evidence on healthcare costs, event rates, and quality of life outcomes. The study involves identifying patients by the HEAR score and troponin levels to categorize risk and assign care accordingly. Low-risk patients are treated conservatively intermediate-risk patients are transferred to the nearest hospital for rapid rule-out or fast-track coronary CT imaging high-risk patients are directly referred to a percutaneous coronary intervention PCI center for invasive coronary angiography. The control group receives standard care with hospital assessment followed by transfer if PCI is needed. This strategy is expected to lead to faster diagnosis, treatment, and improved resource use. Participants will be monitored for major adverse cardiac events including death, confirmed ACS, repeated ACS, and unplanned interventions within 30 days and up to 12 months. Quality of life and healthcare costs will also be assessed over 12 months. The study includes follow-up visits and data collection to evaluate outcomes and cost-effectiveness. Participation involves assessments at enrollment and follow-up periods, with careful safety monitoring throughout the study duration of up to 12 months post-enrollment.